Défi sociétal 'Santé, démographie, bien-être' + les futurs appels

Horizon 2020

Dr Ruxandra Draghia Akli, MD, PhD DG Recherche & Innovation

Commission européenne

Réunion d’information et de mobilisation Défi sociétal 'Santé, démographie, bien-être', Horizon 2020

Paris, 28 novembre 2013

Disclaimer

Pending formal adoption by the EU of the Horizon 2020 legal texts, the content of these slides is not definitive and so should not be taken as such, nor used or referred to as such in any way or for any purpose

Building on the FP7

experience…

• …for collaborative research, global consortia, and public-private co-operation

• …to fund excellent applied health and ageing research and innovation

• …to bring together leading players from Europe and across the globe

• …to tackle key European and global health challenges

FP7 'Health' – the largest multi-national fund…

Building on experience

France – FP7 top performer in Europe

FP7 funding received by country

The French FP7 involvement in figures

578 projects

309 French organisations involved

1122 participations

€828 million total cost

€604 million EU funding

€538,000 EU funding for each participation (average)

Connections with EU Member States

& FP7 Associated countries

Horizon 2020

'Health, demographic

change and wellbeing'

What is Horizon 2020?

− Responding to the economic crisis to invest in future jobs and growth

− Addressing people’s concerns about their livelihoods, safety and environment

− Strengthening the EU’s global position in research, innovation and technology

http://ec.europa.eu/research/horizon2020

The EU’s 2014-20 programme

for research & innovation

A core part of Europe 2020,

Innovation Union &

European Research Area

Horizon 2020 - what's new?

• A single programme bringing together three separate programmes/initiatives*

• Coupling research to innovation – from research to retail, all forms of innovation

• Focus on societal challenges facing European society e.g. health and ageing, clean energy and transport

• Simplified access, for all companies, universities, institutes in all EU countries and beyond

The 7th Research Framework Programme (FP7), innovation aspects of Competitiveness and Innovation Framework Programme (CIP), EU contribution to the European Institute of Innovation and Technology (EIT)

Three priorities

Excellent science

Industrial leadership

Societal challenges

European Research Council (ERC)

Frontier research by the best individual teams

13 095

Future and Emerging Technologies

Collaborative research to open new fields of innovation

2 696

Marie Skłodowska-Curie actions (MSCA)

Opportunities for training and career development

6 162

Research infrastructures (including e-infrastructure)

Ensuring access to world-class facilities

2 488

Proposed funding (million EUR, 2014-2020)*

All funding figures in this presentation are subject to the pending Multiannual Financial Framework Regulation by the EP and the Council

Proposed funding (million EUR, 2014-2020)*

All funding figures in this presentation are subject to the pending Multiannual Financial Framework Regulation by the EP and the Council

Leadership in enabling and industrial technologies (LEITs)

(ICT, nanotechnologies, materials, biotechnology, manufacturing, space)

13 557

Access to risk finance

Leveraging private finance and venture capital for research and innovation

2 842

Innovation in SMEs

Fostering all forms of innovation in all types of SMEs

616 + complemented by

expected 20% of budget of societal challenges + LEITs

and

'Access to risk finance' with strong SME focus

Proposed funding (million EUR, 2014-2020)*

All funding figures in this presentation are subject to the pending Multiannual Financial Framework Regulation by the EP and the Council

Health, demographic change and wellbeing 7 472

Food security, sustainable agriculture and forestry, marine and maritime and inland water research and the bio-economy

3 851

Secure, clean and efficient energy * 5 931

Smart, green and integrated transport 6 339

Climate action, environment, resource efficiency and raw materials

3 081

Inclusive, innovative and reflective societies 1 310

Secure societies 1 695

Science with and for society 462

Spreading excellence and widening participation 816

Strategic Initiatives

Innovative Medicines Initiative 2 www.imi.europa.eu

European & Developing Countries Clinical Trials Partnership (EDCTP2)

www.edctp.org

Active and Assisted Living 2 www.aal-europe.eu

European Innovation Partnership on Active and Healthy Ageing https://webgate.ec.europa.eu/eipaha

• Translating science to benefit citizens

• Improve health outcomes

• Support a competitive health & care sector

• Test and demonstrate new health & care models, approaches and tools

• Promote healthy and active ageing

Horizon 2020 - Societal Challenge 1

Do also look elsewhere! EU support of health related research & innovation is not limited to Societal Challenge 1

Less prescriptive topic texts

Two-year work programme

Stronger focus on end users

Broad topics

Challenge-driven

A new approach

More opportunities for SMEs

• Some 20% of the total budget for societal challenges/LEITs to go to SMEs

• Simplification – a great benefit to SMEs

• A new SME instrument

• 'Innovation in SMEs' - a dedicated activity for research-intensive SMEs

• 'Access to risk finance' with strong SME focus (debt and equity facility)

Image courtesy of Vlado/ FreeDigitalPhotos.net

Wanted: international cooperation

• A priority

• Key goal: more and better international cooperation

• Horizon 2020 is open to participation from across the world

• Targeted actions across the entire programme

• Horizon 2020 Regulation and Rules for Participation apply

Getting you started faster

• A single set of simpler and more coherent participation rules

• New trust/control balance

• Just 2 funding rates for different beneficiaries and activities

• Single flat rate for overhead or 'indirect costs'

• Simpler financial regulation to come

• 8 months time-to-grant exceptions for the ERC and in duly justified cases

Image courtesy of ponsuwan/ FreeDigitalPhotos.net

Next steps

Starting fr

Adoption of work programme and publication of first calls for proposals

11 December 2013

Submission deadlines for your proposals

Two-stage: 11 March & 19 August

All others: 15 April

SME instrument: check Work Programme

Horizon 2020 national launch events

Until January 2014 Full list: http://ec.europa.eu/research/horizon2020

National info days Please check with your national contact points http://ec.europa.eu/research/participants/portal/page/nationalcontactpoint

Collaborative

Research

The draft Work Programme 2014/15 is online

http://ec.europa.eu/research/horizon2020 (in 'Official Documents')

Understanding the call topics: example

'PHC 2 – 2015'

'Specific challenge'

'Scope'

'Expected impact'

'Type of action'

The Work Programme 2014/15 in brief

Call for 'co-ordination activities' 16 topics (10 in 2014, 6 in 2015)

Call 'personalising health and care' 34 topics (15 in 2014, 17 in 2015, 2 open in both years)

€ 1,21 billion

• Understanding health, ageing & disease

• Effective health promotion, disease prevention, preparedness and screening

• Improving diagnosis

• Innovative treatments and technologies

• Advancing active and healthy ageing

• Integrated, sustainable, citizen-centred care

• Improving health information, data exploitation and providing an evidence base for health policies and regulation

Call 'personalising health and care' Seven focus areas

• European Innovation Partnership on Active and Healthy Ageing

• Global Alliance for Chronic Diseases (GACD) – Diabetes (2014)

• Joint Programming Initiative 'More Years, Better Life's (2014)

• Joint Programming Initiative on neurodegenerative diseases (JPND, 2014)

• Global Research Collaboration for Infectious Disease Preparedness (2014)

• European Reference Networks (2015)

Call for 'co-ordination activities' Support for European and International Initiatives

• Joint Programming Initiative on neurodegenerative diseases (JPND, 2014)

• Translational cancer research (2014)

• Systems medicine for clinical needs (2014)

• Rare diseases (2014)

• 2015: Brain-related disorders, antimicrobial resistance, cardiovascular diseases

Call for 'co-ordination activities' Completing the European Research Area

Applying for funding – the process in brief

Publication of the calls

Submission of proposals

Signature grant agreement

Information on the outcome of the evaluator

Time to prepare

the proposal

Preparation

of the grant

Evaluation

Applying for funding – your one-stop shop

http://ec.europa.eu/research/participants/portal

Learn more

http://ec.europa.eu/digital-agenda/en/life-and-work/living-healthy-ageing-well

http://ec.europa.eu/research/health

http://ec.europa.eu/research/participants/portal

http://cordis.europa.eu/home_en.html

Innovative

Medicines

Initiative 2

The biggest public/private partnership in Life Science aiming to:

• Make drug R&D processes in Europe more innovative and efficient

• Enhance Europe’s competitiveness

• Address key societal challenges

Features:

• 1:1 funding, joint decision making

• All EU funds go to SMEs, academia, patient organisations and regulatory agencies

• Large pharmaceutical industry, represented by EFPIA, contributes in-kind

33

Innovative Medicines Initiative: Europe’s fast track to better medicines

IMI state of play

€1.6 bn COMMITTED

€2 bn by end of 2013

42 PROJECTS

+ up to 15 more from calls 8-11

Call 10 application deadline 28 January 2014, 17:00:00 Brussels time Call 11 to be launched in December, indicative text on IMI website

600 Academic & research

teams

388 EFPIA teams

14 regulators

22 patient org.

113 SMEs

In the Pipeline: IMI2

• Commission proposal from 10 July, legislative process ongoing

• Mission: create an even more powerful research and innovation machine, with broader objectives and a wider range of activities and partners

• Proposed budget: €3.45 billion, equally shared between public

and private partners

• Key objectives:

• Pave the way for the breakthrough vaccines, medicines and treatments which we will need in the near future

• Enable top quality research and innovations with great public health benefits and commercial possibilities

European and

Developing

Countries Clinical

Trials Partnership 2

EDCTP – time for renewal

Commission proposal for EDCTP2:

Broader scope + neglected infectious diseases, all clinical phases, diagnostics and delivery optimisation

More EU co-funding almost €700 million

Longer duration 10 years

Timetable • July 2013

Commission adopts proposal (as part of the 'Innovation Investment Package')

• 3 Dec 2013: Competitiveness Council - approval of Council position on the package

• 9 Jan 2014 Committee vote in the European Parliament expected

• First half of 2014 Adoption and start of EDCTP2

From EDCTP1…

Disease profile: HIV/AIDS, TB, Malaria Interventions: Drugs, Vaccines , Microbicides Capacity Building in sub-Saharan Africa

Scope of activities

Disease profile: HIV/AIDS, TB, Malaria, NIDs Interventions: Drugs, Vaccines , Microbicides, Diagnostics Capacity Building in sub-Saharan Africa

…to EDCTP2 Scope of activities

EDCTP2 – annual work plan

Integrated Activities

Activities selected/funded centrally by the EDCTP secretariat Horizon 2020 rules apply with derogation

Minimum: 2 participating states + 1 African partner Participating States Initiated Activities

Selected, funded and managed by states participating in EDCTP Co-funding from the EU contribution, in some cases, Joint Activities with 3rd Parties

EDCTP and a 3rd party publish a call together

Active & Assisted

Living Joint Programme 2

Europe's population is ageing…

Necessity

Opportunity

••• 43

Dependency Ratio

From 1:4 to 1:2

80+ doubles by 2025

Cost of Care

Up by 4-8 % of GDP by 2025

Human Resources

Shrinking work force

Lacking 20 million carrers by 2020

Empowerment

Active Ageing

New Care Models

Integrated care

Large Efficiency gains

Growth and Markets

€3000 billion wealth

85 Million consumers & growing

Ambient Assisted Living

€600 million + EU funding of €150 million

22 European countries

2-3 years to market

120+ projects 40%+ SMEs

• Market-oriented ICT research in assisted living technologies & services

• Strong demand/impact orientation

• Participation according to national rules

• Active and Assisted Living JP

• New instruments e.g. prizes or innovation grants

• Participating countries pay €225 million (indicative)

• EU pays up to €175 million (indicative, ~40% of total public funding)

AAL 2 – setting sail for new horizons

• SME participation of >40%

• Demand side participation ~20%

• Leverage effect: €175 million EU €225 million MS €300 million

private sector

• >25% of projects going to market

• >50% of projects securing IPR

• Time to contract less than 9 months

AAL 2 – setting sail for new horizons

European Innovation

Partnership on

Active and Healthy Ageing

A new approach

• A wide partnership: patients, carers, financers, pharma, ICT, hospitals, ministries …

• A shared vision on ageing in Europe

• Committed to a clear target: 2 more healthy life years by 2020

• Focusing on just 6 work areas and delivery by 2015

• Commitment by "invitation to commit", with public & peer scrutiny

• No ring fenced EU funding

• Stakeholder and political leadership

A network of actions and players

• Action Groups Partners committed to work together on a specific EIP action

• (Candidate) Reference Sites 'EIP best practice' regions

• Marketplace for innovative ideas Open online platform @

1,000 regions &

municipalities

1 billion euro

committed by partners

30 mio citizens,

>2 mio patients

> 500 commitments

in six Action Groups

3,000 partners & 300

leading organisations

32 regions as Reference sites

of Innovative Practices

A critical mass of activity

Marketplace

>45,400 visits >880

registered users

Reference Sites - coverage

32 sites selected for self-

assessment and peer-

review

71 good practices of innovation-based

integrated care models

'Star' ranking = readiness for

replication and coaching

13 Reference Sites

12 Reference Sites

7 Reference Sites

Learn more

• ICT for Ageing Well http://ec.europa.eu/digital-agenda/en/life-and-work/living-healthy-ageing-well

• ICT Policy Support Programme http://ec.europa.eu/ict_psp

• Ambient Assisted Living Joint Programme www.aal-europe.eu

• JPI - More Years – Better Lives www.jp-demographic.eu

• Active and Healthy Ageing Partnership http://ec.europa.eu/active-healthy-ageing

• Contact CNECT-ICT4ageing (at) ec.europa.eu

ruxandra.draghia-akli@ec.europa.eu

Merci beaucoup!